5th International mRNA Health Conference

November 1-2, 2017 / Berlin, Germany

Program & Speakers

The 5th International mRNA Health Conference will provide a comprehensive program around the medical use of messenger RNA.

Read the press release of July 31, 2017


  • Keynotes & Introduction
  • Infectious Disease
  • Cancer
  • Molecular Therapy & Protein Replacement
  • mRNA Delivery & mRNA Design
  • mRNA Product Development


  • Arlen Avakian, Alexion, USA
  • Hayat Bähr-Mahmud, BioNTech, Germany
  • Michela Brazzoli, GSK Vaccines, Italy
  • Karine Breckpot, Vrije Universiteit Brussel, Belgium
  • Stefaan De Koker, eTheRNA Immunotherapies, Belgium
  • Steve Dowdy, UCSD School of Medicine, San Diego, USA
  • Christine Esau, Arcturus Therapeutics, USA
  • Regina Fritsche-Danielson, AstraZeneca, Sweden
  • Thomas Hinz, Paul-Ehrlich-Institut, Germany
  • Ingmar Hoerr, CureVac, Germany
  • Stephen Hoge, Moderna Therapeutics, USA
  • Keiji Itaka, The University of Tokyo, Japan
  • Michael Kormann, Eberhard-Karls-Universität Tübingen, Germany
  • Tom Madden, Acuitas Therapeutics, Canada
  • Smita Nair, Duke University School of Medicine, Durham, USA
  • Chantal Pichon, Université d'Orléans, France
  • Klaus T. Preissner, Justus-Liebig-Universität Giessen, Germany
  • Justin Richner, IIT Research Institute (IITRI), Chicago, USA
  • Ugur Sahin, BioNTech, Germany
  • Schraga Schwartz, Weizmann Institute of Science, Israel
  • Alexandra Stolzing, Loughborough University, Leicestershire, UK
  • Jörg Vogel, University of Würzburg, Germany
  • Drew Weissman, University of Pennsylvania, Philadelphia, USA
  • Lior Zangi, Icahn School of Medicine at Mount Sinai, New York, USA

Call for Abstracts

We invite you to submit an abstract for a potential talk or poster presentation during the 5th International mRNA Health Conference.
The program committee is calling for abstracts in the fields of mRNA-based cancer therapies, vaccines and molecular therapies as well as mRNA delivery, mRNA design and mRNA product development.
Please send your abstract for consideration to abstracts[at]mrna-conference.com. Please indicate whether you are interested in presenting a poster, having a talk or both. The deadline for submission is September 8, 2017.

Instructions for Abstract Submission

Abstracts are to be submitted as Word documents (.doc/.docx) in the following format:

  • Font: Arial, Text size: 12pt
  • Title: Bold in upper and lower case letters
  • First and last name(s) of each author(s), separated by comma(s) (in upper and lower case letters)
  • Institution Name, City, State, Country (each affiliation should be numbered to associate with the respective author’s name)
  • Abstract body text should be provided as a single paragraph without any subheadings
  • The full abstract text (including title and author information) should not exceed 3,000 characters including spaces
  • Please do not include any citation, figure or table in your abstract
  • Double check your special characters and use SI units throughout the abstract text